The Commercialization Gap at HBCUs, By the Numbers

Every year, MIT reports over $80 million in total licensing revenue. Harvard's commercialization revenue runs $59–152 million annually. Stanford's typical royalty income lands in the $45–65 million range. That money isn't magic — it's the output of decades-old technology-transfer offices, in-house company builders, and dedicated capital networks.

Historically Black Colleges and Universities are not behind on research. Many report $40–84 million in annual sponsored research, active patent portfolios across materials science, agriculture, and biotech, and growing research infrastructure. What's been missing isn't the science. It's the path from a faculty disclosure to a licensed, capitalized company.

What a real engine looks like

A functioning technology-transfer engine does six things well:

1. Intake and triage — every disclosure gets a written response, fast, so nothing sits in a drawer.
2. Commercial evaluation — market sizing, freedom-to-operate, and a clear build/pass call.
3. IP and licensing strategy — patent support and license terms that meet, not undercut, the R1 benchmark.
4. Company formation — an actual business plan and an operator to run it, not just a licensed patent.
5. Capital — first checks from day one, stretched by non-dilutive grants.
6. Reporting and stewardship — a pipeline the administration can see and govern.

Most under-resourced institutions have zero to two of these six. That's the gap Just Builds is built to close — at no cost to the university until a company is actually formed and licensed on terms the institution approves.